Corporate GovernanceMay 28, 2026, 04:09 PM
Corcept Stockholders Approve 8M Share Increase for Incentive Plan
AI Summary
Corcept Therapeutics Incorporated held its 2026 Annual Meeting of Stockholders, where several key proposals were approved. Stockholders voted to approve an amendment to the 2024 Incentive Award Plan, increasing the number of shares available thereunder by 8,000,000. Additionally, eight directors were elected, the appointment of Ernst & Young LLP as the independent auditor for 2026 was ratified, and the compensation of named executive officers was approved on an advisory basis.
Key Highlights
- Stockholders approved an amendment to the 2024 Incentive Award Plan, increasing available shares by 8,000,000.
- Eight directors were elected to serve until the 2027 annual meeting of stockholders.
- Ernst & Young LLP was ratified as the independent auditor for fiscal year 2026 with 92,656,473 votes for.
- Named executive officers' compensation was approved on an advisory basis with 72,511,429 votes for.
- A total of 93,270,175 shares were voted at the Annual Meeting.
Price Impact
More from CORT